Omnicell Technologies (OMCL) Insider Sells $617,533.28 in Stock


Omnicell Technologies (NASDAQ:OMCL) insider Robin Gene Seim sold 13,286 shares of the firm’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $46.48, for a total value of $617,533.28. Following the completion of the transaction, the insider now directly owns 74,121 shares in the company, valued at $3,445,144.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.


Shares of Omnicell Technologies traded down $0.60, reaching $46.00, during trading hours on Wednesday, Marketbeat.com reports. 8,463 shares of the company traded hands, compared to its average volume of 286,253. The stock has a market cap of $1.83 billion, a P/E ratio of 258.89, a PEG ratio of 2.17 and a beta of 0.76. Omnicell Technologies has a 12-month low of $46.00 and a 12-month high of $46.45. The company has a quick ratio of 1.22, a current ratio of 1.68 and a debt-to-equity ratio of 0.33.

Get Omnicell Technologies alerts:

Omnicell Technologies (NASDAQ:OMCL) last issued its earnings results on Thursday, April 26th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.04. The company had revenue of $182.60 million for the quarter, compared to the consensus estimate of $177.49 million. Omnicell Technologies had a return on equity of 4.11% and a net margin of 4.55%. The firm’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter last year, the company earned $0.06 EPS. equities research analysts expect that Omnicell Technologies will post 1.38 earnings per share for the current fiscal year.


Several brokerages have issued reports on OMCL. Oppenheimer reissued a “buy” rating and issued a $55.00 target price on shares of Omnicell Technologies in a research report on Monday, January 29th. BidaskClub cut Omnicell Technologies from a “sell” rating to a “strong sell” rating in a research report on Friday, January 19th. Craig Hallum cut Omnicell Technologies from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Cantor Fitzgerald reaffirmed a “buy” rating and set a $63.00 price objective on shares of Omnicell Technologies in a research report on Thursday, February 1st. Finally, Zacks Investment Research raised Omnicell Technologies from a “sell” rating to a “hold” rating in a research report on Friday, February 2nd. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $56.67.


Large investors have recently added to or reduced their stakes in the business. Louisiana State Employees Retirement System boosted its holdings in Omnicell Technologies by 7.2% during the 4th quarter. Louisiana State Employees Retirement System now owns 16,300 shares of the company’s stock valued at $791,000 after acquiring an additional 1,100 shares during the period. Teachers Advisors LLC boosted its holdings in Omnicell Technologies by 1.3% in the fourth quarter. Teachers Advisors LLC now owns 94,008 shares of the company’s stock valued at $4,559,000 after purchasing an additional 1,220 shares during the period. Teachers Retirement System of The State of Kentucky lifted its holdings in Omnicell Technologies by 3.1% during the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 41,456 shares of the company’s stock worth $2,010,000 after buying an additional 1,233 shares during the last quarter. California Public Employees Retirement System lifted its holdings in Omnicell Technologies by 1.6% during the 4th quarter. California Public Employees Retirement System now owns 87,628 shares of the company’s stock worth $4,250,000 after buying an additional 1,388 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan lifted its holdings in Omnicell Technologies by 9.9% during the 1st quarter. Municipal Employees Retirement System of Michigan now owns 15,490 shares of the company’s stock worth $672,000 after buying an additional 1,390 shares during the last quarter.


Omnicell Technologies Company Profile

Omnicell, Inc provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, a software which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Anesthesia Workstation that manages anesthesia supplies and medications.

Insider Buying and Selling by Quarter for Omnicell Technologies (NASDAQ:<b><a href=OMCL)' title='Insider Buying and Selling by Quarter for Omnicell Technologies (NASDAQ:OMCL)' />